Rudy Mazzocchi
Chief Executive Officer at Gsl Healthcare, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Hancock | M | 75 |
ABT Innovations, Inc.
 ABT Innovations, Inc. BiotechnologyHealth Technology Part of Asep Medical, Inc., ABT Innovations, Inc. manufactures peptide products for inflammatory medications. The company is based in Victoria, Canada. The Canadian company was founded in 2015 by Robert E. W. Hancock. The CEO is Rudy A. Mazzocchi. ABT Innovations was acquired by Asep Medical, Inc. on May 14, 2021 for $2.06 million.
Asep Medical, Inc.
 Asep Medical, Inc. Financial ConglomeratesFinance Asep Medical, Inc. invests in the healthcare sector. The private company is based in Victoria, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Rudy A. Mazzocchi. | 9 years |
| Joseph Dziedzic | M | 55 | 11 years | |
| Timothy Murphy | M | 53 |
Asep Medical, Inc.
Asep Medical, Inc. Financial ConglomeratesFinance Asep Medical, Inc. invests in the healthcare sector. The private company is based in Victoria, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Rudy A. Mazzocchi. | 3 years |
| Derrold Norgaard | M | 62 |
Asep Medical, Inc.
Asep Medical, Inc. Financial ConglomeratesFinance Asep Medical, Inc. invests in the healthcare sector. The private company is based in Victoria, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Rudy A. Mazzocchi. | 3 years |
| Jennifer Gretchen | F | 36 |
Asep Medical, Inc.
Asep Medical, Inc. Financial ConglomeratesFinance Asep Medical, Inc. invests in the healthcare sector. The private company is based in Victoria, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Rudy A. Mazzocchi. | 2 years |
| Dennis Condon | M | 75 | 7 years | |
| Edward Schutter | M | 72 | 9 years | |
| Nicholas Lewin | M | 46 | 9 years | |
| Fadia Saad | M | 61 |
Asep Medical, Inc.
Asep Medical, Inc. Financial ConglomeratesFinance Asep Medical, Inc. invests in the healthcare sector. The private company is based in Victoria, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Rudy A. Mazzocchi. | 3 years |
| Robert G. Koblin | M | 92 |
University of California, Los Angeles
| 42 years |
| G. Richard Patton | M | 72 |
University of Pittsburgh
| 48 years |
| Alberto Quesada | M | 58 | 7 years | |
| Michael Graw | M | - |
Asep Medical, Inc.
Asep Medical, Inc. Financial ConglomeratesFinance Asep Medical, Inc. invests in the healthcare sector. The private company is based in Victoria, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Rudy A. Mazzocchi. | - |
| Evan Haney | M | 42 | 3 years | |
| Mike Graw | M | - |
ABT Innovations, Inc.
ABT Innovations, Inc. BiotechnologyHealth Technology Part of Asep Medical, Inc., ABT Innovations, Inc. manufactures peptide products for inflammatory medications. The company is based in Victoria, Canada. The Canadian company was founded in 2015 by Robert E. W. Hancock. The CEO is Rudy A. Mazzocchi. ABT Innovations was acquired by Asep Medical, Inc. on May 14, 2021 for $2.06 million. | - |
| Richard Heinzl | M | - |
Next Health, Inc
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marco Benedetti | M | 65 |
Greatbatch, Inc.
| 10 years |
| Peter J. Alvarado | M | 67 |
University of Pittsburgh
| 7 years |
| Martine Rothblatt | M | 69 |
University of California, Los Angeles
| 5 years |
| Patrick W. Dennis | M | - |
University of California, Los Angeles
| 3 years |
| Bernhard A. Sabel | M | - |
NovaVision, Inc.
 NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | - |
| Martin Edward Doerfler | M | - |
University of Pittsburgh
| 8 years |
| David Francis | M | - |
University of Pittsburgh
| 3 years |
| Brian M. Albert | M | - |
University of Pittsburgh
| 7 years |
| Jeffrey K. Norman | M | - |
University of Pittsburgh
| 9 years |
| Holger Weis | M | 61 |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | 4 years |
| Jo Ann Haller | F | - |
University of Pittsburgh
| 7 years |
| Bob Sydow | M | 69 |
University of California, Los Angeles
| 3 years |
| Lisa Colleran | F | 66 | 8 years | |
| José A. Avila | M | 68 |
University of Pittsburgh
| 2 years |
| John R. Watters | M | - |
University of California, Los Angeles
| 3 years |
| Ronald Dean Ormand | M | 65 |
University of California, Los Angeles
| 6 years |
| John Booth | M | 70 |
Microvena Corp.
| 3 years |
| Allan M. Weinstein | M | 75 | 3 years | |
| Gregg Feinberg | M | - |
University of Pittsburgh
| 7 years |
| Navroze S. Mehta | M | - |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | 8 years |
| Thirumalai M. Ravi | M | - |
University of California, Los Angeles
| 7 years |
| Montague Yort | M | 60 |
University of California, Los Angeles
| 10 years |
| Kathryn Falberg | F | 63 |
University of California, Los Angeles
| 7 years |
| Robert D. Monsour | M | 73 |
University of Pittsburgh
| 8 years |
| David Hung | M | 66 | 5 years | |
| Dennis Haines | M | 69 |
University of Pittsburgh
| 7 years |
| Mark A. Nordenberg | M | 75 |
University of Pittsburgh
| 37 years |
| Al Neupaver | M | 73 |
University of Pittsburgh
| 3 years |
| Kjirsten Mickesh | F | - | 5 years | |
| Robert H. Flory | M | - |
University of Pittsburgh
| - |
| Andrew Firlik | M | - |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | 18 years |
| Rodrigo A. Guerra | M | 68 |
University of California, Los Angeles
| 5 years |
| Michael M. Kagawa | M | - |
University of California, Los Angeles
| 18 years |
| A. Judson Hill | M | 69 |
University of Pittsburgh
| 5 years |
| Osman Kaldirim | M | 71 |
University of California, Los Angeles
| 2 years |
| Min-Jui Shen | M | 60 |
University of California, Los Angeles
| 4 years |
| Karen A. Dempsey | F | - |
University of California, Los Angeles
| 4 years |
| Kenneth T. Shimizu | M | - |
University of California, Los Angeles
| 4 years |
| Suzanne Wilson-Higgins | F | 64 |
University of California, Los Angeles
| 4 years |
| Hung Yu Shiah | M | 62 |
University of California, Los Angeles
| 3 years |
| Karen Malmuth Kaufmann | M | - |
University of California, Los Angeles
| 4 years |
| Hobart Lee Epstein | M | 67 |
University of California, Los Angeles
| 2 years |
| Brad Peterson | M | 62 |
University of California, Los Angeles
| 3 years |
| Todd Randall Walsh | M | - |
University of California, Los Angeles
| 14 years |
| Ken Hertz | M | 66 |
University of California, Los Angeles
| 3 years |
| James Belardi | M | 67 |
University of California, Los Angeles
| 2 years |
| Jane McLaughlin | F | - |
University of California, Los Angeles
| 2 years |
| Steven L. Canepa | M | - |
University of California, Los Angeles
| 4 years |
| Steven Eric Martz | M | - |
University of California, Los Angeles
| 4 years |
| Thomas T. Marshall | M | - |
University of California, Los Angeles
| 4 years |
| Makoto C. Ning | M | 66 |
University of California, Los Angeles
| 5 years |
| Therese Llorente | F | - |
University of California, Los Angeles
| 4 years |
| Guy Speers | M | - |
University of California, Los Angeles
| 4 years |
| Di Wang | M | 66 |
University of California, Los Angeles
| 4 years |
| Jay F. Shepherd | M | - |
University of California, Los Angeles
| 4 years |
| Robert D. Lenhard | M | - |
University of California, Los Angeles
| 3 years |
| Stephen A. Maas | M | - |
University of California, Los Angeles
| 3 years |
| Marc E. Bercoon | M | - |
University of California, Los Angeles
| 3 years |
| Robert D. Geringer | M | 64 |
University of California, Los Angeles
| 4 years |
| Vincent M. Scardina | M | - |
University of California, Los Angeles
| 2 years |
| Arvind Relan | M | 61 |
University of California, Los Angeles
| 1 years |
| John Jeffrey Sobel | M | 65 |
University of California, Los Angeles
| 4 years |
| David C. Kwan | M | - |
University of California, Los Angeles
| 2 years |
| Michael J. Shearer | M | - |
University of California, Los Angeles
| 4 years |
| Joanne Elise Hagopian | F | - |
University of California, Los Angeles
| 4 years |
| Esfandiar Lohrasbpour | M | 68 |
University of California, Los Angeles
| 3 years |
| Michael Howse | M | - |
University of California, Los Angeles
| 4 years |
| Bill Gignac | M | - |
University of California, Los Angeles
| 3 years |
| Robert Kimzey | M | - |
University of California, Los Angeles
| 4 years |
| Daniel Magid | M | - |
University of California, Los Angeles
| 4 years |
| Jan Loeys | M | - |
University of California, Los Angeles
| 5 years |
| Larry Prager | M | - |
University of California, Los Angeles
| 2 years |
| John S. Benson | M | - |
University of California, Los Angeles
| 2 years |
| Eric J. Emanuel | M | - |
University of California, Los Angeles
| 3 years |
| Nancy Ellen Freeman | F | - |
University of California, Los Angeles
| 1 years |
| Paul Grayson | M | - |
University of California, Los Angeles
| 4 years |
| Kevin R. Martin | M | - |
University of California, Los Angeles
| 4 years |
| Terry Theodore | M | - |
University of California, Los Angeles
| 5 years |
| Fumio Urano | M | 81 |
University of California, Los Angeles
| 4 years |
| Guy N. Halgren | M | - |
University of California, Los Angeles
| 3 years |
| Frank L. Buckley | M | - |
University of California, Los Angeles
| 5 years |
| Jar-How Lee | M | - |
University of California, Los Angeles
| 3 years |
| David Carey | M | - |
University of California, Los Angeles
| 4 years |
| Hamad Abdullah Al-Attiyah | M | - |
University of California, Los Angeles
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 84 | 84.00% |
| Canada | 9 | 9.00% |
| Costa Rica | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rudy Mazzocchi
- Personal Network
